Newsroom

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.

Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.

Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.

Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.